Business

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

WALTHAM, Mass., January 29, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

articleThermo Fisher Scientific IncJanuary 29, 202614/company/thermo-fisher-scientific-inc/news/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2025-results
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

About this update from Thermo Fisher Scientific Inc

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1590,"height":341,"url":"https://media.zenfs.com/en/business-wire.com/c3d95497c2424f89aabfba10d399b505"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s.OelO_OD9zJ2.7cDSAPdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c3d95497c2424f89aabfba10d399b505","width":960,"height":206},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ygskfDjS4C9xcEORDQX_OA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/c3d95497c2424f89aabfba10d399b505","width":1200,"height":257}},"lazy":false},{"type":"text","content":"WALTHAM, Mass., January 29, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.","length":229,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year 2025 Highlights","length":44,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Fourth quarter revenue grew 7% to $12.21 billion.","length":49,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Fourth quarter GAAP diluted earnings per share (EPS) grew 9% to $5.21.","length":70,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Fourth quarter adjusted EPS grew 8% to $6.57.","length":45,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":164,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Full year revenue grew 4% to $44.56 billion.","length":44,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Full year GAAP diluted earnings per share (EPS) grew 7% to $17.74.","length":66,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Full year adjusted EPS grew 5% to $22.87.","length":41,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":151,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Delivered another year of excellent operational performance and share gain reflecting our active management of the company, the strength of our proven growth strategy and the power of our PPI Business System.","length":208,"tagName":"p","attribs":{}...

More updates from Thermo Fisher Scientific Inc

Thermo Fisher ScientificFisher Scientificfourth quarteroperating margingrowth strategyoperational performance